A

Autolus Therapeutics

682 employees

Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.

Investor insights

Funding rounds participated in

$350M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

2014

Funding rounds raised

Total raised

$350M

from investors over 1 rounds

A

Autolus Therapeutics raised $350M on March 8, 2024